TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,298 Cr | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr | ₹-1,651 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2,298 Cr |
| Mar2024 | ₹-2,780 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹-1,781 Cr |
| Mar2021 | ₹-1,651 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2,298 Cr | Negative | |
| Mar2024 | ₹-2,780 Cr | Negative | |
| Mar2023 | ₹77 Cr | Positive | |
| Mar2022 | ₹-1,781 Cr | Negative | |
| Mar2021 | ₹-1,651 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹150,628.6 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
| MANKIND PHARMA | ₹99,864.1 Cr | -6.4% | 6.7% | -3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.5% |
8.2% |
39% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses